Double action
to counteract the
Metabolic Syndrome
Nutraceutical Support with an Advanced Innovative Formulation, effective in:
Metabolic alterations are frequently associated with disorders such as obesity, abdominal adiposity, insulin resistance and cardiovascular risk factors.
EGREGIA contains multiple forms of RESVERATROL, which guarantee prolonged absorption over time.
Revifast® acts on multiple levels, playing an important role in COUNTERACTING clinical signs:
RevifastlipoTM Technology
Combined with the Resveratrol Synergy from Revifast®and Alpha-Lipoic Acid, it allows for clear clinical benefits to be achieved.
Double action to counteract the Metabolic Syndrome
The Resveratrol synergy from Revifast®and Alpha-Lipoic Acid performs:
Improves glycemic parameters in women with Gestational Diabetes
The effectiveness of Egregia has been demonstrated by clinical studies conducted on: Overweight Women
Clinically tested in Pregnancy, it improves glycemic parameters in women with Established Gestational Diabetes
How to take Egregia
The recommended daily dose is to take 2 tablets a day for 15 days and then one tablet a day thereafter between meals.
Beneficial effects are noticeable with continuous use of the product for at least 3 months, which may be extended according to the recommendation of the medic.
